CCL2 and Nephropathy: The results demonstrated significantly elevated levels of MCP-1 in SCD patients along with a positive correlation between MCP-1 and malondialdehyde levels, suggesting its potential as a biomarker for kidney damage associated with SCD as well as reflecting oxidative stress-induced harm present within this condition.